Zebrafish is a powerful tool in pharmacological research and useful to identify new therapies. Probiotics can offer therapeutic options in alcoholic liver disease. This study was done in two independent experiments: first, we confirmed the intestinal colonization of probiotic Lactobacillus rhamnosus GG (LGG) after ethanol exposure. Second, four groups were performed: control (C), probiotic (P), ethanol (E), and probiotic+ethanol (P+E). Liver histology, hepatocytes morphometry, hepatic and serum lipid quantifications were conducted in second experiment. During 4 weeks, P and P+E groups were fed with LGG supplemented feed; E and C unsupplemented. E and P+E groups received 0.5% of ethanol added into tank water. Zebrafish exposed to ethanol (E group) presented intense liver steatosis after 28 days in contrast to the almost normalized liver histology of P+E group at the same period. Liver morphometry showed a significant enlargement of hepatocytes of E group after 4 weeks (p<0.0001). Serum triglycerides decreased in P+E group compared with C, P (p<0.001), and E (p=0.004), after 14 and 28 days similarly. Serum cholesterol was also decreased by LGG; P group decreased compared with C and E after 14 days (p=0.002 and p=0.007, respectively) and P+E group decreased significantly compared with E and C groups (p<0.0001) after 28 days. Hepatic triglycerides were reduced in P+E group after 28 days compared to E (p=0.006). The persistence of LGG in zebrafish intestines was demonstrated. LGG decreased serum levels of triglycerides and cholesterol and improved hepatic steatosis.
Get full access to this article
View all access options for this article.
References
1.
GaoB, BatallerR. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology, 2011; 141:1572–1585.
2.
TranS, GerlaiR. Time-course of behavioral changes induced by ethanol in zebrafish (Danio rerio). Behav Brain Res, 2013; 252:204–213.
3.
RicoEP, RosembergDB, DiasRD, BogoMR, BonanCD. Ethanol alters acetylcholinesterase activity and gene expression in zebrafish brain. Toxicol Lett, 2007; 174:25–30.
4.
ArenzanaFJ, CarvanMJ, AijónJ, Sánchez-GonzálezR, ArévaloR, PorterosA. Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol Teratol, 2006; 28:342–348.
5.
HowarthDL, PasseriM, SadlerKC. Drinks like a fish: using zebrafish to understand alcoholic liver disease. Alcohol Clin Exp Res, 2011; 35:1–4.
6.
PurohitV, BodeJC, BodeC, BrennerDA, ChoudhryMA, HamiltonF. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol, 2008; 42:349–361.
7.
MutluE, KeshavarzianA, EngenP, ForsythCB, SikaroodiM, GillevetP. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res, 2009; 33:1836–1846.
8.
RawlsJF, SamuelBS, GordonJI. Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota. Proc Natl Acad Sci U S A, 2004; 101:4596–4601.
9.
CantasL, RogerJ, SørbyJ, AlestromP, SørumH. Culturable gut microbiota diversity em zebrafish. Zebrafish, 2012; 9:26–37.
10.
KekkonenRA, Sysi-AhoM, Seppänen-LaaksoT, JulkunenI, VapaataloH, OresicM, et al.Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults. World J Gastroenterol, 2008; 14:3188–3194.
11.
ElmadfaI, KleinP, MeyerAL. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proc Nutr Soc, 2010; 69:416–420.
12.
ZhangL, LiN, CaicedoR, NeuJ. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr, 2005; 135:1752–1756.
13.
CarnevaliO, AvellaMA, GioacchiniG. Effects of probiotic administration on zebrafish development and reproduction. Gen Comp Endocrinol, 2013; 188:297–302.
14.
AvellaMA, PlaceA, DuSJ, WilliamsE, SilviS, ZoharY, et al.Lactobacillus rhamnosus accelerates zebrafish backbone calcification and gonadal differentiation through effects on the GnRH and IGF systems. PLoS One, 2012; 7:e45572.
15.
WilsonJM, BunteRM, CartyAJ. Evaluation of rapid cooling and tricaine methanesulfonate (MS222) as methods of euthanasia in zebrafish (Danio rerio). J Am Assoc Lab Anim Sci, 2009; 48:785–789.
16.
GerlaiR, LahavM, GuoS, RosenthalA. Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav, 2000; 67:773–782.
17.
MeurerF, HayashiC, BoscoloWR. Apparent digestibility of some protein sources for Nile tilapia. Rev Bras Zootec, 2003; 32:1801–1809.
18.
HerGM, HsuCC, HongJR, LaiCY, HsuMC, PangHW, et al.Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta, 2011; 1811:536–548.
19.
SadlerKC, AmsterdamA, SorokaC, BoyerJ, HopkinsN. Genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development, 2005; 132:3561–3572.
20.
PedrosoGL, HammesTO, EscobarTD, FracassoLB, ForgiariniLF, da SilveiraTR. Blood collection for biochemical analysis in adult zebrafish. J Vis Exp, 2012; e3865.
21.
FolchJ, LeesM, StanleyGHS. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem, 1957; 226:497–509.
22.
de AssisAM, RechA, LongoniA, RottaLN, DenardinCC, PasqualiMA, et al.Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. Mol Cell Biochem, 2012; 361:151–160.
23.
SozioM, CrabbDW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab, 2008; 295:E10–E16.
24.
Bull-OttersonL, FengW, KirpichI, WangY, QinX, LiuY, et al.Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One, 2013; 8:e53028.
25.
GorbachSL. Probiotics and gastrointestinal health. Am J Gastroenterol, 2000; 95:2–4.
26.
GuarnerF, MalageladaJR. Gut flora in health and disease. Lancet, 2003; 361:512–519.
27.
IannittiT, PalmieriB. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr, 2010; 29:701–725.
28.
LorentK, YeoSY, OdaT, ChandrasekharappaS, ChitnisA, MatthewsRP, et al.Inhibition of Jagged-mediated Notch signaling disrupts zebrafish biliary development and generates multi-organ defects compatible with an Alagille syndrome phenocopy. Development, 2004; 131:5753–5766.
29.
BaraonaE, LieberCS. Effects of ethanol on liver metabolism. J Lipid Res, 1979; 20:289–315.
30.
RimmEB, WilliamsP, FosherK, CriquiM, StampfeMJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ, 1999; 319:1523–1528.
31.
AungLH, YinRX, WuDF, CaoXL, HuXJ, MiaoL. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels. Int J Med Sci, 2013; 10:124–132.
32.
WakabayashiI. Associations of alcohol drinking and cigarette smoking with serum lipid levels in healthy middle-aged men. Alcohol Alcohol, 2008; 43:274–280.
33.
KumarM, RakeshS, NagpalR, HemalathaR, RamakrishnaA, SudarshanV, et al.Probiotic Lactobacillus rhamnosus GG and Aloe vera gel improve lipid profiles in hypercholesterolemic rats. Nutrition, 2013; 29:574–579.
34.
PavlovićN, StankovK, MikovM. Probiotics-interactions with bile acids and impact on cholesterol metabolism. Appl Biochem Biotechnol, 2012; 168:1880–1895.
35.
OoiLG, LiongMT. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci, 2010; 11:2499–2522.
36.
PereiraDI, GibsonGR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem and Mol Biol, 2002; 37:259–281.
37.
WangY, KirpichI, LiuY, MaZ, BarveS, McClainCJ, et al.Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol, 2011; 179:2866–2875.
38.
RitzeY, BardosG, ClausA, EhrmannV, BergheimI, SchwiertzA, et al.Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One, 2014; 9:e80169.
39.
NikoskelainenS. OuwehandAC, BylundG, SalminenS, LiliusE. Immune enhancement in rainbow trout (Oncorhynchus mykiss) by potential probiotic bacteria (Lactobacillus rhamnosus). Fish Shellfish Immunol, 2003; 15:443–452.
40.
PanigrahiA, KironV, SatohS, HironoI, KobayashiT, SugitaH, et al.Immune modulation and expression of cytokine genes in rainbow trout Oncorhynchus mykiss upon probiotic feeding. Dev Comp Immunol, 2007; 31:372–382.
41.
PiraratN, PinpimaiK, EndoM, KatagiriT, PonpornpisitA, ChansueN, et al.Modulation of intestinal morphology and immunity in nile tilapia (Oreochromis niloticus) by Lactobacillus rhamnosus GG. Res Vet Sci, 2011; 91:e92–e97.
42.
GioacchiniG, GiorginiE, OlivottoI, MaradonnaF, MerrifieldDL, CarnevaliO. The influence of probiotics on zebrafish Danio rerio innate immunity and hepatic stress. Zebrafish, 2014; 11:98–106.
43.
NosovaT, Jousimies-SomerH, JokelainenK, HeineR, SalaspuroM. Acetaldehyde production and metabolism by human indigenous and probiotic Lactobacillus and Bifidobacterium strains. Alcohol Alcohol, 2000; 35:561–568.
